I agree with can do, statistically small sample but if representative then 4% is 4%. I think I may have doubled up on riba twice in 11 weeks. I need to change my methodology and practice more diligent recording.
I want to see next test and improvements. This is good news and now some problems have been identified and can be addressed. That is one reason they package the incivek in separate pia blister packs. That is why they preload syringes for peg.. All issues that can be addressed. This is a good thing.
Just to save myself some time (sick of googling...lol) how many are usually in phase II trials? There were just 88 in this trial, and I think we "know" a lot of them. Do most phase II trials have hundreds, thousands, or what is the usual average amount?
And can-do-man...not upset...more like frustrated. And neither was directed at you. My CAPS were more to emphasize my points.. and my questions... and I have always welcomed your opinions on any and all posts I make.
Petition update: 5876 have signed
No need to get upset as I said its just my opinion and yes 4% is alot to have serious effects, dosing or not. Besides a study of only 88 does not impress me.
As I also said the results sound very good, time will tell.
"...only THREE cases were judged to be related to the study medicines and ALL occurred when patients ACCIDENTALLY took EXTRA doses of daclatasvir or GS-7977".
So if as you calculate...4% of the people had SERIOUS adverse events...do you not see it as ALL related to OVERDOSING of the trial drugs???????
Doesn't matter...I will take my chances and just NOT take more than prescribed AMOUNT when (not IF) I get my hands on these two drugs...GS-7977 + daclatasvir (without Ribavirin_!!
Petition update: 5797 people have signed for the CURE for Hepatitis C
Sign & share this petition if you want the chance at this life-saving drug combination!
http://www.change.org/petitions/gilead-sciences-please-collaborate-with-bristol-myers-for-the-cure-for-hepatitis-c-now